Relapsed/metastatic anal cancer

The names of the lead clinicians for the IRCI Relapsed/metastatic anal cancer group include:

Professor Dirk Arnold (EORTC)
Dr Al Benson (US)
Dr Rob Glynne-Jones (UK)

Current active trial

InterAAct – A Phase II International Multicentre Randomized Advanced Anal Cancer Trial Comparing Cisplatin plus 5FU vs. Carboplatin plus Weekly Paclitaxel in Patients with Relapsed or Metastatic Disease (International Rare Cancers Initiative study – IRCI 003)

› Read more

Informative websites

Cancer Help, Cancer Research UK

National Cancer Institute

Institut National Du Cancer


Rare Cancer Types

Active groups

Closed groups